Sensus Healthcare Inc SRTS.OQ SRTS.O is expected to show a rise in quarterly revenue when it reports results on November 14 for the period ending September 30 2024
The Boca Raton Florida-based company is expected to report a 51.2% increase in revenue to $5.895 million from $3.9 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for Sensus Healthcare Inc is for a loss of 1 cent per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Sensus Healthcare Inc is $10.00, above its last closing price of $7.15.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2024 | 0.02 | 0.02 | 0.10 | Beat | 328.6 |
Mar. 31 2024 | -0.06 | -0.05 | 0.14 | Beat | 354.5 |
Dec. 31 2023 | 0.14 | 0.12 | 0.26 | Beat | 113.1 |
Sep. 30 2023 | -0.01 | -0.02 | -0.09 | Missed | -400 |
Jun. 30 2023 | -0.08 | -0.08 | -0.02 | Beat | 73.7 |
Mar. 31 2023 | 0.12 | 0.13 | -0.12 | Missed | -193.7 |
Dec. 31 2022 | 0.25 | 0.23 | 0.17 | Missed | -26.1 |
Sep. 30 2022 | 0.12 | 0.13 | 0.11 | Missed | -12.7 |
This summary was machine generated November 13 at 00:04 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments